b'D. Treatment of LipedemaIntroduction 31Lipedema Diagnosis . 31Imaging of Lipedema . 31Treatment of Lipedema:Conservative Management 32Surgical Management. 32 SECTION 2: COMPLEX LYMPHATIC ANDVASCULAR ANOMALIESA. Clinical Features and Diagnosis . 33 History and Physical Examination.34B. Management of Vascular and other Complex Malformations,for Overlapping Vascular and Lymphatic Donditions .34C. Management of Protein-losing Enteropathies, Chylothorax, Chyloperitoneum .35D. Medical Management of mTOR Inhibitors/Other Pharmacotherapies for Lymphatic Malformations and Complex Vascular Lesions .35E. Interventional Therapies in the Treatment of Lymphatic and Vascular AnomaliesVenous and Lymphatic Sclerotherapy 36Thoracic Duct Embolization for Plastic Bronchitis, Chylothorax, and Chyloperitoneum .36SECTION 3. CONSULTATIVE SERVICESFOR LYMPHATIC DISEASESA. Genetics (Screening for Known Genes and Mutations, Genetic Counseling to Patients and Families) 36B. Mental Health Introduction .38 Physical Effects 38 Psychological Effects .39 Social Effects 39 Psychotherapeutic Considerations 39 Psychopharmacologic Considerations .41 Limitations in the State of Evidence 41SECTION 4: GUIDELINES FOR COMMUNICATION INLYMPHEDEMA AND LYMPHATIC DISEASESA. Introduction 42B. Communication Functions 42 Managing Uncertainty .42 Exchanging Information .42 Making Decisions .42 Building Relationships43 Enabling Self-Management .43 Responding to Emotions .43 Supporting Hope .43 Providing Validation .44C. Conclusion .44SECTION 5: FINAL REMARKS 44References 45| Standardized Approach for the Diagnosis and Management of Lymphedema (LE) and Lymphatic Diseases (LD)|3'